Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-13

Clinical Trial Update: PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing PK/PD and safety of remazolam besylate for injection in ICU patients with impaired renal function who are mechanically ventilated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remazolam Besylate (remazolam besylate)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Mechanically Ventilated Patients | Phase 2 | Status: UNKNOWN